BioSpace News Archive

Business

BioSpace Movers and Shakers, July 19

Pharma and biotech companies from across the globe expand their leadership teams and boards.

July 18, 2019
·
5 min read
·
Alex Keown
Business

Acacia Pharma - Founder Dr. Julian Gilbert steps down - Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

July 18, 2019
·
5 min read
Business

Vince Ippolito appointed as Botanix Executive Chairman

Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience, appointed as Executive Chairman of Botanix Pharmaceuticals

July 18, 2019
·
3 min read
Drug Development

MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi

MyoKardia, Inc. announced updates related to its hypertrophic cardiomyopathy treatment portfolio, including lead therapeutic candidate, mavacamten.

July 18, 2019
·
7 min read
Business

Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals

Bridge Biotherapeutics licensed out its BB-877 to Boehringer Ingelheim for a total deal of about $1.75 billion. This is the second large deal for fibrotic diseases Boehringer Ingelheim inked since the beginning of the month.

July 18, 2019
·
3 min read
·
Mark Terry
Business

Novartis Close to Settling Kickback Lawsuit

Novartis saw a strong boost in sales during the second quarter, driven by Cosentyx and Entresto, as well as a 9% growth in oncology sales, the company announced this morning.

July 18, 2019
·
3 min read
·
Alex Keown
Deals

Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019

Assertio Therapeutics, Inc. announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019, after the close of markets.

July 18, 2019
·
1 min read
Eisai Presents Nonclinical Research Results of Elenbecestat at AAIC 2019

Without Significant Effects on Synaptic Function in Brain by Spinal Densitiy Evaluation at Effective Dose to Decrease Amyloid Beta Level in Cerebrospinal Fluid at Alzheimer’s Association International Conference (AAIC) 2019

July 18, 2019
·
5 min read
Drug Development

InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa

InflaRx reported additional in-depth analysis of the completed double blind, placebo controlled part of the ongoing international SHINE Phase IIb study to supplement InflaRx’s top line disclosure of results reported on June 5, 2019.

July 18, 2019
·
10 min read
Genetown

Tuning the Body’s Genes to Fight against Health Threats

Scientists have long known that our environment can affect the way our genes work, a process called gene expression.

July 18, 2019
·
3 min read